NEWS | Innovation for Life

SINGAPORE, [01 November 2022] / Prestige Biopharma Limited, a Singapore-based leading biopharmaceutical company, announced that the CEO of its subsidiary, Prestige Biopharma Korea, received 2022 Foreign Company Day award in South Korea.

The ceremony was held on 1st of November 2022 at Intercontinental Hotel Seoul to award 44 companies’ representatives orders and merits of honor for their contribution to boosting Foreign Direct Investment (FDI) to South Korea.

The CEO of Prestige Biopharma Korea, Tay Lai Wat, was awarded the commendation of the Ministry of Trade, Industry and Energy (MOTIE) minister for his commitment to FDI to South Korea.